FDA Pulls Authorization for Evusheld, Says It’s Ineffective Against New COVID Mutations
Packaging and vials for AstraZeneca's Evusheld antibody COVID-19 medication. (AstraZeneca via AP)
Packaging and vials for AstraZeneca's Evusheld antibody COVID-19 medication. (AstraZeneca via AP)